Mr. Rashid Ahmed reports

BIOMARK ANNOUNCES OTCQB LISTING

Biomark Diagnostics Inc. has commenced trading on OTCQB, the venture market for entrepreneurial and development-stage companies. OTC Markets Group announced today that Biomark Diagnostic has been verified for trading on OTCQB, effective Feb. 17, 2015.

"We are very pleased to add Biomark to our expanding universe of OTCQB companies," commented Douglas Rogers, managing director of Merriman Capital's capital markets advisory group. "Advising our clients on best practices regarding their material information and financial reporting requirements is a key component of our advisory platform at Merriman. We look forward to supporting the Biomark management team on the OTCQB market."

Rashid Ahmed, president and chief executive officer, said: "This is a significant milestone for the company as it aims to increase its presence among American retail and institutional investors, providing enhanced liquidity. We are grateful for the hard work Merriman Capital has undertaken to help us achieve our listing on the OTCQB."

Biomark will continue to trade on the Canadian Stock Exchange under its existing symbol BUX.

We seek Safe Harbor.